Thu.Jan 18, 2024

article thumbnail

Navigating A Unique Journey: Dr. Lindsey Moseley’s Inspiring Path in Pharmacy Education

Pharmacy Is Right For Me

A pharmacy education provides diverse opportunities, ranging from patient care and research to education. Truly, no one path looks the same and there is no better example than Dr. Lindsey Moseley who found her passion for teaching and education whilst pursuing her Pharm.D. degree. Facing An Identity Crisis Dr. Lindsey Moseley is the Curricular Coordinator and a faculty member at Auburn University Harrison College of Pharmacy.

article thumbnail

Florida Drug Importation Program Faces Nationwide Opposition From Pharmacy Organizations

Drug Topics

Just weeks after it gained FDA approval, pharmacy organizations have come forward to voice concerns about the safety and security of Florida’s drug importation program.

FDA 227
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

No Significant Differences in Efficacy Shown Between Reference Drug, Biosimilars in Patients With IBD

Pharmacy Times

Despite the insignificant differences in efficacy, biomarkers, therapeutic drug level, and ADAs, patients reported a significant number of nocebo effects.

153
153
article thumbnail

Vaccine Innovation Continued in 2023 with Several Important Approvals

Drug Topics

In 2023, the FDA approved six vaccines, including 2 for respiratory syncytial virus (RSV), and the first vaccine to prevent the mosquito-borne virus chikungunya.

Vaccines 187
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Could long Covid’s signs of immune dysregulation in the blood lead to a diagnostic test?

STAT

Long Covid has long eluded scientists looking for its cause. Not knowing what triggers its persistent and distressing symptoms makes the condition challenging to treat; it’s hard to even say definitively who has it. New research published Thursday in Science has identified proteins present in the blood of people with long Covid that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets.

article thumbnail

For Patients With Chronic Inflammation, Poverty Increases Cardiovascular Risk

Pharmacy Times

In general, poverty negatively impacts physical and mental health, and those in poverty have greater risks of mental illness, heart disease, hypertension, and stroke.

132
132

More Trending

article thumbnail

Global Prevalence of Sleep Disorders Demands a Team-Based Approach

Pharmacy Times

Because medications to treat these conditions are often controlled substances, including pharmacists on the multidisciplinary team (MDT) is invaluable.

article thumbnail

Pumping breastmilk in bathrooms is a common, albeit unspoken, practice at health care conferences

STAT

Even though Erin Booth was not thrilled about having to travel to Philadelphia for a conference at six weeks postpartum, this one at least advertised having a private lactation space. This was back in 2013, when such accommodations were a rarity. The first bad sign was having to walk clear across the convention center to get there, cutting into her already brief pumping window.

145
145
article thumbnail

Celebrities Don’t Persuade Patients to Get Vaccinated; Pharmacists Do

Pharmacy Times

Despite Travis Kelce’s recent commercial with Pfizer, data show celebrity endorsements do not convince listeners to receive immunizations

Vaccines 139
article thumbnail

STAT+: The FDA’s diagnostics chief, who led through Covid, has retired

STAT

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.  During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests.

FDA 145
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Business Group: These are the top healthcare challenges employers expect to face this year

Fierce Healthcare

Self-insured employers are set to face plenty of challenges this year, ranging from addressing the mental health needs of their workforces to developing strategies for on-site clinics amid a pivot | Mental health, pharmacy costs and vendor partnerships among the top healthcare concerns for large, self-insured employers, according to a report by the Business Group on Health.

Insurance 125
article thumbnail

Bernie Sanders proposes subpoenas of CEOs of J&J, Merck on drug prices

STAT

WASHINGTON — Senate health committee chair Bernie Sanders has taken a step toward subpoenaing the CEOs of Johnson & Johnson and Merck related to an investigation into high drug prices in the United States, he announced Thursday. The step is highly unusual, as the health committee hasn’t issued a subpoena in more than 40 years.

142
142
article thumbnail

Study: Ultraviolet Light Could Destroy Coronavirus Particles

Pharmacy Times

The researchers found that the genomic material was extremely sensitive to the degradation.

162
162
article thumbnail

STAT+: Microsoft to embed AI tool for clinical documentation in Epic’s health records software

STAT

Microsoft on Thursday said it will launch its artificial intelligence tool for automating clinical documentation within health records software made by Epic, a move to embed the technology in health systems nationwide. The AI product, known as Dax Copilot, will automatically draft notes through Epic’s mobile application, known as Haiku, making it available for immediate review by clinicians.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Digital Therapeutic AspyreRx Can Help Patients With T2D Reduce Costs, Manage Condition

Drug Topics

Through interactive lessons, skill-building modules and weekly goal setting and tracking, AspyreRx allows patients to connect changes in behavior to improvements in blood sugar and other biometrics.

98
article thumbnail

STAT+: Klobuchar urges drugmakers to remove patents FTC calls improper and inaccurate

STAT

Amid a push to crack down on patent abuse by the pharmaceutical industry, a key U.S. lawmaker is urging six large drug companies to remove dozens of patents that were identified by regulators as improperly or inaccurately listed with a federal registry. In a series of letters sent on Thursday, Sen. Amy Klobuchar (D-Minn.) demanded the companies explain why they have, so far, not responded to warnings issued two months ago by the Federal Trade Commission to remove more than 100 patents from the r

136
136
article thumbnail

Epic launches new 'Showroom' website for 3rd-party apps, services

Fierce Healthcare

As part of an initiative teased last summer, Epic officially launched this week new third-party vendor programs to connect health tech companies with health systems and providers. | As part of an initiative teased last summer, Epic officially launched this week new third-party vendor programs to connect health tech companies with health systems and providers.

121
121
article thumbnail

Amid a dire nationwide therapist shortage, could lay counselors help close the gap?

STAT

One morning last May, 10 students and two instructors from across California gathered on Zoom to talk about empathy. Empathy, said instructor Elizabeth Morrison, is often undervalued. But it’s a crucial skill for any effective mental health care provider. People who find their way into this academy, she said, tend to already have a lot of empathy and be good at communicating it.

article thumbnail

After Pfizer offers discount, NICE gives thumbs up to breast cancer drug Talzenna

Fierce Pharma

Six months after England’s National Institute for Health and Care Excellence (NICE) spurned Pfizer’s breast cancer treatment Talzenna (talazoparib) because it was not cost effective, the agency has | Six months after England’s National Institute for Health and Care Excellence spurned Pfizer’s breast cancer treatment Talzenna because it was not cost effective, the agency has reversed course following the company’s offer to slash the price.

120
120
article thumbnail

STAT+: How digital therapeutics companies are improvising when insurance coverage isn’t guaranteed

STAT

For years, the playbook for many companies that wanted to market digital therapeutics was stupid simple: Sell it like a prescription drug. But just because it was simple didn’t mean it was going to work. The bankruptcy of Pear Therapeutics last year proved that selling software-based treatments like drugs is harder than anticipated. Pear received Food and Drug Administration clearance for its app treating substance use disorders and insomnia but insurers mostly refused to cover the novel

article thumbnail

Senators threaten to subpoena CEO testimony while J&J, Merck claim retaliation amid IRA legal fight

Fierce Pharma

In its efforts to probe high U.S. drug prices, the Senate health committee has already heard from the heads of Moderna, Eli Lilly, Novo Nordisk and Sanofi. | The Senate Committee on Health, Education, Labor, and Pensions will vote on issuing subpoenas at the end of the month after the Johnson & Johnson and Merck CEOs refused to testify at an upcoming hearing.

118
118
article thumbnail

STAT+: Apple Watch pulse oximeter feature removed to comply with ban

STAT

Apple will remove the blood oxygen measurement feature from its Apple Watches, the company announced Thursday. It’s the latest twist in a saga between Apple and medical device company Masimo. The International Trade Commission issued an import ban against Apple Watches in October after finding the blood oxygen feature too similar to Masimo’s.

121
121
article thumbnail

The Significance of Community Pharmacies' Services Beyond Dispensing Separation

Pharmacy Times

Pharmacists in community-based settings are now capable of developing innovative pharmacy practices and offering patient care services.

article thumbnail

Payer Roundup–Humana confirms layoffs; Medicaid expansion linked to lung cancer survival

Fierce Healthcare

Below is a round-up of payer-centric news for the week of Jan. 15., 2024 | This week, Humana announced workforce reductions, a study associated Medicaid expansion with reduced lung cancer mortality and Bright Health moved its corporate headquarters.

115
115
article thumbnail

Understanding the impact of AI on the advancement of gene therapy development

pharmaphorum

This page explores the significant impact of artificial intelligence (AI) on the advancement of gene therapy development within the biopharmaceutical field.

120
120
article thumbnail

Financial distress fueled more hospital M&A deals in 2023, report finds

Fierce Healthcare

Hospitals’ immediate financial needs drove more than a quarter of the sector’s merger and acquisition activity through 2023, which also brought a higher overall number of unveiled transactions than | The portion of hospitals and health systems whose transactions followed dire financial situations was nearly double that of 2020, 2021 and 2022, Kaufman Hall wrote in a recent report.

Hospitals 112
article thumbnail

STAT+: Humana slashes profit predictions amid soaring Medicare Advantage costs

STAT

Humana’s Medicare Advantage enrollees got care in the hospital and physician clinics way more often than the company predicted at the end of 2023, forcing the health insurance giant on Thursday to drastically slash its profit projections for both 2023 and 2024. Those higher medical costs will wipe away more than $775 million of profit that Humana had expected to bank for 2023.

Insurance 111
article thumbnail

NICE backs Pfizer’s Talzenna for advanced breast cancer

pharmaphorum

Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recommended by NICE for routine NHS use.

110
110
article thumbnail

Senate passes short-term funding bill, House expected to follow

Fierce Healthcare

The Senate voted 77-18 to pass a bill Thursday that would punt a partial government shutdown, set to go into effect this weekend, back to early March. | The bill again pushes back a scheduled $8 billion-per-year cut to Medicaid disproportionate share hospital program payments and extends funding for community health centers, this time to March 8.

Hospitals 110
article thumbnail

Will Congress get any health policy done this year?

STAT

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. Inside Congress’ health care policy breakdown Lawmakers are headed toward passage of a stopgap spending bill that funds the same health programs as the last one — but things were almost different, I scooped last night.

109
109
article thumbnail

Key themes from JP Morgan

pharmaphorum

pharmaphorum editor-in-chief Jonah Comstock is back from San Francisco, where he attended the annual JP Morgan Healthcare Conference. In today’s podcast episode, guest host Eloise McLennan interviews him about what he saw and heard at the show.

108
108
article thumbnail

Biotech layoffs, slumping stocks, and a 2024 preview

STAT

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital.

FDA 107
article thumbnail

What are the side effects of Bactrim for older adults?

The Checkup by Singlecare

If you’ve ever had a bacterial infection, it’s possible your healthcare provider prescribed a medication called Bactrim to treat it. Bactrim (or Bactrim DS for the double-strength version)—which is also sold as Sulfatrim or Septra—is the brand name for a combination medication containing two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat various bacterial infections, such as urinary tract infections, bronchitis, traveler’s diarrhea, and pneumonia.

article thumbnail

Study shows takotsubo cardiomyopathy treated incorrectly with myocardial infarction drugs

Hospital Pharmacy Europe

Heart treatments given to patients with takotsubo cardiomyopathy do not protect them and the condition is not being treating correctly, according to a new study comparing these patients with myocardial infarction patients and the general population. Published in the journal JACC: Advances and funded by the British Heart Foundation , the researchers analysed health records from 3,720 people in Scotland to investigate cardiovascular mortality and medication use after takotsubo cardiomyopathy – for

Hospitals 105